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Intra-articular metallic gold micro particles relieve pain 
and enhance function in patients with knee osteoarthritis
A pilot study
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Conclusions
Intra-articular metallic gold improved joint 
pain, stiffness and function. The increased 
pressure pain threshold indicate less joint hy-
peralgesia. Intra articular gold particles may 
modify the synovial inflammation as a part of 
the sensitization in knee OA patients. In this 
cohort of patients with moderate to severe 
knee osteoarthritis and synovial effusion in-
tra-articular metallic gold relieved pain and 
enhanced function in more than 80 % of the 
patients. This study suggests a basis for a 
future placebo controlled randomized trial 
in OA patients.
Aim of Investigations
Many patients suffering from osteoarthritis (OA) do not 
get adequate pain relieve. Current therapies relieve pain 
to some extent and up to 30 % having an arthroplasty do 
not achieve sufficient improvement.
Animal studies indicate gold ions have a long-acting effect 
on OA pain. The immuno-modulatory effect of gold ions 
have for more than 50 years a known anti-inflammatory 
effect in the treatment of rheumatic arthritis. Gold ions 
alter the function of macrophages by inhibiting lysosomal 
enzymes and lowering production of pro-inflammatory 
cytokines(1-2).
Dissolucytotic metallic gold (DMG) ions have an im-
mune-suppressive effect in laboratory testing(3-5) (Figure 
1-3). Animal studies prove the effect of gold implantation 
in arthritic joints(6-9). Injection of DMG in animal models 
stimulate the immune system(10-11). The carrier for inject-
ing the DMG micro particles is hyaluronic acid (12-13).
No studies have investigated the effect of intraarticular 
gold micro particle implants for treatment of knee osteo-
arthritis in humans. The present open, pilot study aimed 
to investigate if gold ions have a role in treating knee os-
teoarthritis(14).
Methods
A cohort of 30 patients referred for treatment of knee 
OA, aged ≥18years, pain ≥ 3 months, synovial effusion on 
MRI, and Kellgren-Lawrence OA grade 3-4 were included. 
Exclusion criteria were malignancy, active infection and 
antibiotic treatment, active treatment with steroids, bi-
ological or other anti-Rheumatic medication, inability to 
comply with the protocol, inadequacy in written and spo-
ken national language. Of 38 eligible patients, 32 met the 
criteria, 1 did not attend and 1 refused. Age was 63 (46-
75) year, BMI 28.8 (22.8-41.7), 18 were men 12 women.
Metallic gold 20 mg, 72.000 pieces, 20-40 my-meter in 
diameter (Berlock-Micro-Implants, BMI, Goldtreat APS) 
(12-13) were injected into the knee joint using the patient’s 
own synovial fluid as the carrier. Outcome measures 
were WOMAC pain, stiffness and function, PainDetect 
questionnaire, and Quantitative Sensory Testing (QST) 
(pressure pain threshold assessed over the knee joint) at 
inclusion and after 8 weeks.
Results
Pain and function improved in 25 of 30 patients. Womac 
pain decreased from 9 (6-16) to 3 (0-15), stiffness from 
4 (1-8) to 2 (0-8), function from 29 (14-51) to 11 (0-
41) (Figure 4), PainDetect decreased from 10 (1-26) to 
3 (0-19) (Figure 5). Pain pressure thresholds increased 
(anti-hyperalgesia) from 598 kPa (276-1043) to 616 kPa 
(349-1089) (Figure 6). All differences, P < 0.05 (Wilcox-
on sign test).
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Figure 1: Macrophages controls the dissolution membrane which liberate 
the gold ions by oxidation of the surface. Once the ions are liberated, most 
likely as Dicyanogold [Au(CN)2]-, they are free to diffuse through the imme-
diate microenvironment. The gold-loaded molecules are taken up into the 
cells, primarily  macrophages, mastcells and histocytes. 
Figure 2: Close to the gold implant gold-loaded molecular clusters are lo-
cated outside cells. The two loaded cells are believed to be macrophages 
loaded with gold ions. The gold ions accumulate primarily in the lysosymes. 
3. Danscher G. Histochem Cell Biol 2002; 117:447–452
Figure 3: Once in the intercellular fluid and the intracellular compartments, 
i.e. lysosomes, the gold ions act in the same ways that have been demon-
strated for systemically administered gold ions. Gold ions suppress inflam-
mation locally probably partly by affecting certain signalling molecules and 
binding enzymes essential for the inflammatory process. The reduced pro-
duction of pro-inflammatory cytokines might relate to the ability of the gold 
ions to unfold the protein structures.
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